Medical Oncology

Diffuse Parenchymal Lung Disease

Questions discussed in this category

In elderly patients with advanced melanoma and idiopathic pulmonary fibrosis receiving active antifibrotic therapy, would neoadjuvant or adjuvant immune checkpoint inhibition be preferred?

3 Answers available

Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?

6 Answers available

Is there a role for nintedanib in the management of patients with radiation-induced pulmonary fibrosis?

1 Answer available

Is there a role of everolimus or capecitabine and temozolomide in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia in patients already on octreotide?

1 Answer available

Papers discussed in this category

Chest, 2020 Aug 14

Clinical Characteristics of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: A Retrospective Analysis.

Chest, 2020 Jul

Somatostatin Analogs Improve Respiratory Symptoms in Patients With Diffuse Idiopathic Neuroendocrine Cell Hyperplasia.

ERJ Open Res, 2020 Oct

Constrictive bronchiolitis in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia.

International journal of radiation oncology, biology, physics, 2023 Mar 07

Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation Pneumonitis.

Journal of the Endocrine Society, 2022 Dec 02

Perioperative Evaluation and Management of Patients on Glucocorticoids.

Diagnostics (Basel, Switzerland), 2021 Apr 20

Glucocorticoid Withdrawal-An Overview on When and How to Diagnose Adrenal Insufficiency in Clinical Practice.

The New England journal of medicine, 2017-11-09

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.

The New England journal of medicine, 2024 Jun 19

Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.

Cancer, 2024 Jun 06

Long-term efficacy of neoadjuvant-adjuvant targeted therapy in borderline resectable stage IIIB-D and IV melanoma.

Related Topics in Medical Oncology